
		Effective Date
New, Revised or Amended Standards and Interpretations		Announced by IASB
Amendments to IAS 21 “Lack of Exchangeability”		January 1, 2025

The Company believes that the adoption of the above amendments to IFRSs did not have a material impact on its consolidated financial statements.

In preparing the accompanying consolidated financial statements, the Company has not adopted the following IFRS Accounting Standards (“IFRS”), International Accounting Standards (“IAS”), Interpretations developed by the International Financial Reporting Interpretations Committee (“IFRIC”) or the former Standing Interpretations Committee (“SIC”) issued by the International Accounting Standards Board (“IASB”) (collectively, “IFRSs”).


		Effective Date
New, Revised or Amended Standards and Interpretations		Announced by IASB
Amendments to IFRS 10 and IAS 28 “Sale or Contribution of Assets Between an Investor and Its Associate or Joint Venture”		Effective date to be determined by IASB
Amendments to IFRS 9 and IFRS 7 “Amendments to the Classification and Measurement of Financial Instruments”		January 1, 2026
Annual Improvements to IFRS Accounting Standards—Volume 11		January 1, 2026
IFRS 18 “Presentation and Disclosure in Financial Statements”		January 1, 2027
IFRS 19 “Subsidiaries without Public Accountability: Disclosures” and amendments to IFRS 19 “Subsidiaries without Public Accountability: Disclosures”		January 1, 2027

As of the date of the consolidated financial statements were authorized for issue, the Company continues in assessing possible impacts that application of the abovementioned amendments will have on the Company’s financial position and financial performance and will disclose these impacts when the assessment is completed.